Uniphar (LSE:UPR) Beta: 1.5697 (As of Jun. 25, 2026)


LSE:UPR Uniphar PLC LSE:UPR
84 GF Score
Price £4.10
GF Value £3.03
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Uniphar Beta?

Uniphar LSE:UPR +4.33% 84 Beta is 1.5697 as of Jun. 25, 2026. GuruFocus rates LSE:UPR with a GF Score™ of 84/100 and a GF Value™ of £3.03 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), Uniphar's Beta is 1.5697.


Uniphar  (LSE:UPR) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Uniphar Beta Related Terms


Uniphar Beta Historical Data

* Premium members only.

The historical data trend for Uniphar's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Uniphar Beta Chart

Uniphar Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 1.40 1.14 1.26

Uniphar Semi-Annual Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.40 1.13 1.14 1.27 1.26

LSE:UPR vs MCK, COR, CAH: Beta Comparison

For the Medical Distribution subindustry, Uniphar's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Uniphar Beta vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Uniphar's Beta distribution charts can be found below:

* The bar in red indicates where Uniphar's Beta falls into.


LSE:UPR
84GF Score
Uniphar PLC LSE:UPR
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Uniphar Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.5697 mean?
Uniphar (LSE:UPR) has a Beta of 1.5697 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Uniphar and its competitors.
Is Uniphar's Beta too high?
Uniphar's current Beta is 1.5697. Overall, Uniphar has a GF Score™ of 84/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Uniphar's Beta compare to MCK and COR?
Uniphar's Beta of 1.5697 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Distribution company?
A good Beta depends on the Medical Distribution industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Uniphar and its competitors. Uniphar's current Beta is 1.5697. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Uniphar stock overvalued right now?
Based on GuruFocus' analysis, Uniphar (LSE:UPR) is currently considered Significantly Overvalued. The stock's GF Value™ is £3.03, compared to a current price of £4.10 — trading 35.3% above its estimated fair value. The current Beta is 1.5697. Uniphar's overall GF Score™ is 84/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Uniphar (LSE:UPR), the current Beta is 1.5697 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Uniphar (LSE:UPR) Overvalued in 2026?

Based on GuruFocus' analysis, Uniphar stock appears to be overvalued. The current stock price of £4.10 is trading 35.3% above its estimated GF Value™ of £3.03. GuruFocus considers Uniphar to be Significantly Overvalued.

Key valuation signals for LSE:UPR:

  • Beta: 1.5697
  • GF Value™: £3.03 vs. price of £4.10 (35.3% above fair value)
  • GF Score™: 84/100 with 9 warning signs

No single metric tells the full story. See the LSE:UPR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Uniphar Business Description

Other Exchanges UPR:Ireland0NR:Germany
Address 4045 Kingswood Road, Citywest Business Park, Dublin, IRL, D24 V06K
Uniphar PLC is a service provider within the pharmaceutical and healthcare sector. The company is an international diversified healthcare services business servicing the requirements of multinational pharmaceutical and medical technology manufacturers across three divisions - Uniphar Pharma, Uniphar Medtech and Uniphar Supply Chain & Retail. Uniphar Pharma enables pharma and biotech companies to bring medicines to markets globally and provide healthcare professionals with access to medicines that can't be sourced through traditional channels. Uniphar Medtech is a Pan-European medical device distributor and solutions partner. Uniphar Supply Chain & Retail is the pharmaceutical wholesaler in Ireland offering of retail pharmacies.
84GF Score

Get the complete analysis for LSE:UPR

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£4.10
Price
£3.03
GF Value